Cargando…
Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
Antimicrobial resistance is well-known to be a global health and development threat. Due to the decrease of effective antimicrobials, re-evaluation in clinical practice of old antibiotics, as fosfomycin (FOS), have been necessary. FOS is a phosphonic acid derivate that regained interest in clinical...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352792/ https://www.ncbi.nlm.nih.gov/pubmed/37469601 http://dx.doi.org/10.3389/fcimb.2023.1178547 |
_version_ | 1785074587121221632 |
---|---|
author | Mattioni Marchetti, Vittoria Hrabak, Jaroslav Bitar, Ibrahim |
author_facet | Mattioni Marchetti, Vittoria Hrabak, Jaroslav Bitar, Ibrahim |
author_sort | Mattioni Marchetti, Vittoria |
collection | PubMed |
description | Antimicrobial resistance is well-known to be a global health and development threat. Due to the decrease of effective antimicrobials, re-evaluation in clinical practice of old antibiotics, as fosfomycin (FOS), have been necessary. FOS is a phosphonic acid derivate that regained interest in clinical practice for the treatment of complicated infection by multi-drug resistant (MDR) bacteria. Globally, FOS resistant Gram-negative pathogens are raising, affecting the public health, and compromising the use of the antibiotic. In particular, the increased prevalence of FOS resistance (FOS(R)) profiles among Enterobacterales family is concerning. Decrease in FOS effectiveness can be caused by i) alteration of FOS influx inside bacterial cell or ii) acquiring antimicrobial resistance genes. In this review, we investigate the main components implicated in FOS flow and report specific mutations that affect FOS influx inside bacterial cell and, thus, its effectiveness. FosA enzymes were identified in 1980 from Serratia marcescens but only in recent years the scientific community has started studying their spread. We summarize the global epidemiology of FosA/C2/L1-2 enzymes among Enterobacterales family. To date, 11 different variants of FosA have been reported globally. Among acquired mechanisms, FosA3 is the most spread variant in Enterobacterales, followed by FosA7 and FosA5. Based on recently published studies, we clarify and represent the molecular and genetic composition of fosA/C2 genes enviroment, analyzing the mechanisms by which such genes are slowly transmitting in emerging and high-risk clones, such as E. coli ST69 and ST131, and K. pneumoniae ST11. FOS is indicated as first line option against uncomplicated urinary tract infections and shows remarkable qualities in combination with other antibiotics. A rapid and accurate identification of FOS(R) type in Enterobacterales is difficult to achieve due to the lack of commercial phenotypic susceptibility tests and of rapid systems for MIC detection. |
format | Online Article Text |
id | pubmed-10352792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103527922023-07-19 Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat Mattioni Marchetti, Vittoria Hrabak, Jaroslav Bitar, Ibrahim Front Cell Infect Microbiol Cellular and Infection Microbiology Antimicrobial resistance is well-known to be a global health and development threat. Due to the decrease of effective antimicrobials, re-evaluation in clinical practice of old antibiotics, as fosfomycin (FOS), have been necessary. FOS is a phosphonic acid derivate that regained interest in clinical practice for the treatment of complicated infection by multi-drug resistant (MDR) bacteria. Globally, FOS resistant Gram-negative pathogens are raising, affecting the public health, and compromising the use of the antibiotic. In particular, the increased prevalence of FOS resistance (FOS(R)) profiles among Enterobacterales family is concerning. Decrease in FOS effectiveness can be caused by i) alteration of FOS influx inside bacterial cell or ii) acquiring antimicrobial resistance genes. In this review, we investigate the main components implicated in FOS flow and report specific mutations that affect FOS influx inside bacterial cell and, thus, its effectiveness. FosA enzymes were identified in 1980 from Serratia marcescens but only in recent years the scientific community has started studying their spread. We summarize the global epidemiology of FosA/C2/L1-2 enzymes among Enterobacterales family. To date, 11 different variants of FosA have been reported globally. Among acquired mechanisms, FosA3 is the most spread variant in Enterobacterales, followed by FosA7 and FosA5. Based on recently published studies, we clarify and represent the molecular and genetic composition of fosA/C2 genes enviroment, analyzing the mechanisms by which such genes are slowly transmitting in emerging and high-risk clones, such as E. coli ST69 and ST131, and K. pneumoniae ST11. FOS is indicated as first line option against uncomplicated urinary tract infections and shows remarkable qualities in combination with other antibiotics. A rapid and accurate identification of FOS(R) type in Enterobacterales is difficult to achieve due to the lack of commercial phenotypic susceptibility tests and of rapid systems for MIC detection. Frontiers Media S.A. 2023-07-04 /pmc/articles/PMC10352792/ /pubmed/37469601 http://dx.doi.org/10.3389/fcimb.2023.1178547 Text en Copyright © 2023 Mattioni Marchetti, Hrabak and Bitar https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Mattioni Marchetti, Vittoria Hrabak, Jaroslav Bitar, Ibrahim Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat |
title | Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat |
title_full | Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat |
title_fullStr | Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat |
title_full_unstemmed | Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat |
title_short | Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat |
title_sort | fosfomycin resistance mechanisms in enterobacterales: an increasing threat |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352792/ https://www.ncbi.nlm.nih.gov/pubmed/37469601 http://dx.doi.org/10.3389/fcimb.2023.1178547 |
work_keys_str_mv | AT mattionimarchettivittoria fosfomycinresistancemechanismsinenterobacteralesanincreasingthreat AT hrabakjaroslav fosfomycinresistancemechanismsinenterobacteralesanincreasingthreat AT bitaribrahim fosfomycinresistancemechanismsinenterobacteralesanincreasingthreat |